|
Contact
|
Newsletter
|
Deutsch
Home
Subgroups
Bayer AG (Holding Company)
Bayer HealthCare
Bayer CropScience
Bayer MaterialScience
Bayer Business Services
Bayer Technology Services
Currenta
Topics
Business & Finance
Research & Innovation
Products
Responsible Care
Social Responsibility
Bayer People
Europe
North America
Asia & Pacific
Central-/Latin America
Africa & Middle East
Press Contact
Bayer AG
(Holding Company)
Bayer HealthCare
Bayer CropScience
Bayer MaterialScience
Bayer Business Services
Bayer Technology Services
Photo-Service
Biographies
Board of Management
Subgroups
Speeches
Photos
Bayer AG (Holding Company)
Bayer HealthCare
Bayer CropScience
Bayer MaterialScience
Bayer Business Services
Bayer Technology Services
Currenta
Education and Training
Research
Locations
Environmental Protection
BayKomm
TV Service
Business & Finance
Research & Innovation
Products
Responsible Care
Social Responsibility
Bayer People
Europe
North America
Asia & Pacific
Central-/Latin America
Africa & Middle East
Bayer Links
Bayer Global
Bayer HealthCare
Bayer CropScience
Bayer MaterialScience
Bayer Business Services
Bayer Technology Services
Currenta
Special Interest
Investor Relations
Jobs and Career
Foundations
Sports
Culture
General Conditions of Use
Privacy Statement
Imprint
Topics
Research & Innovation
|
|
1 - 20
|
21 - 40
|
41 - 44
|
Monday - January 26, 2009
20 new jobs to be created after investment of EUR 22 million
Bayer builds world's largest production plant for carbon nanotubes in Chempark Leverkusen
Construction start-up followed by kick-off event of the Innovationsallianz CNT in Leverkusen
Monday - January 12, 2009
Bayer Schering Pharma signs agreement with Micromet:
Exclusive licensing option for solid tumor antibody
Thursday - January 8, 2009
Molecular Imaging:
Bayer Schering Pharma enhances research in cancer imaging
Licensing agreement with Hamamatsu Photonics K.K., Japan
Friday - December 12, 2008
New Technologies and Products Presented at the Perspective on Innovation 2008:
Bayer Strengthens Research and Development
Bayer innovations provide solutions for the global challenges of the future / Pharmaceutical pipeline is well filled, with 50 projects currently in phases I to III of clinical testing / Ten new crop protection active ingredients are to come onto the market between 2008 and 2012 / Bayer Chairman Wenning calls for tax breaks for research and development, better patent protection, increased efforts in education policy and a higher acceptance of technology
|
|
1 - 20
|
21 - 40
|
41 - 44
|
Print page
Search
Advanced Search
Publications
Stockholders' Newsletter
Annual Report
Sustainable Development Report
The Bayer Climate Program
research – The Bayer Scientific Magazine
Publications Overview
Newsletter
We will keep you informed about the latest news.
Events
Friday, February 26, 2010
Annual Report 2009 / Financial News Conference Full Year 2009
Contact:
Günter Forneck
Additional Press Events
Investor Relations Events
Sport Events
BayKomm Events
Download Center - Selection
Your selection:
0
Download(s)